The Ras superfamily of small GTPases has over 150 human members, with conserved orthologs found throughout the eukaryotic phyla. Ras superfamily GTPases function as GDP/GTP-regulated molecular switches, and are important for many aspects of cell and developmental biology as well as oncogenesis. We are studying the C. elegans orthologs of two human small GTPase subfamilies whose functions are poorly understood. DRN-1(C54A12.4) is the C. elegans ortholog of the human Di-Ras1/Rig, Di-Ras2 and Noey2/ARH1 subfamily of the Ras family. Di-Ras1 expression is frequently lost or down-regulated in neural tumor-derived cell lines and primary human neural tumors, and Noey2 expression is lost in many breast and ovarian cancers. These observations suggest that this subfamily functions as tumor suppressors, in contrast to most Ras family members, which are oncogenes. Preliminary experiments show that ectopic over-expression of DRN-1 can cause embryonic lethality. However, a null mutation in
drn-1 causes no obvious phenotypes. A
drn-1 promoter transcriptional GFP fusion and a full-length
drn-1 translational fusion both showed expression in a subset of head, ventral cord and tail neurons. Close examination of morphology and function in of these cells in null mutant and gain-of-function transgenic animals will help us to identify a
drn-1 mutant phenotype. CHW-1(F22E12.2) is the C. elegans ortholog of the human Chp (Cdc 42 homologous protein) and Wrch (Wnt-regulated Cdc 42 homolog) subfamily of the Rho family. Human Chp and Wrch both promote formation of filopodia and activate the PAK serine/threonine kinase, and are implicated in cell transformation. Thus Chp and Wrch appear to be oncogenic, like many Rho family members. Transgenes with a genomic clone of
chw-1 caused embryonic lethality, suggesting that CHW-1 over-expression can perturb development. However, a null mutation in
chw-1 caused no obvious defects.
chw-1 promoter transcriptional GFP fusions are expressed in body wall and enteric muscles, but not pharyngeal and egg laying muscles. Expression was particularly high in the anal depressor muscle. We plan a closer examination of muscles in
chw-1 null and gain-of-function transgene animals. For both
drn-1 and
chw-1, we plan to exploit gain-of-function phenotypes for suppressor screens to identify downstream signaling components. This is of particular interest with
drn-1, since little is known about signaling downstream of the Di-Ras subfamily.